Investigations Into Sepsis-associated Acute Kidney Injury

Overview

In this study the investigators would like to study systemic and regional disturbances in patients with sepsis-associated acute kidney injury and in healthy controls undergoing laparoscopic abdominal surgery. Specifically study metabolic, hemodynamic and oxygen transport variables.

Full Title of Study: “Investigations Into the Mechanisms for Bioenergetic Failure in Sepsis-associated Acute Kidney Injury”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2023

Detailed Description

Acute kidney injury (AKI) in patients with sepsis has a very poor prognosis with up to 60% mortality. The pathobiology remains to be fully understood. Creatine and phosphocreatine, products of arginine metabolism through L-arginine:glycine amidinotransferase (AGAT) and its sister enzyme guanidinoacetate N-methyl-transferase (GAMT), provide an energy-buffering system that is essential for intracellular adenosine triphosphate (ATP) supply. We hypothesized that sepsis associated AKI may be caused by failure of this energy-buffering system. In series of pilot studies, we explored metabolic and bioenergetic patterns in patients and animals with high risk of developing AKI. These data suggest that sepsis associated AKI may be caused by failure of this alternative renal energy source. In the current application we propose a clinical investigation of renal metabolism and renal bioenergetics in patients with high and low risk of developing sepsis associated AKI. The primary objective is to directly investigate renal AGAT activity through the arginyl metabolites homoarginine, guanidino acetate, and creatine. Secondary objectives are to study renal and systemic hemodynamics, renal oxygenation, glomerular filtration rate (GFR), renal tubular function, and mitochondrial respiration.

Interventions

  • Drug: Para Aminohippurate
    • Measurements of renal plasma flow and glomerular filtration rate

Arms, Groups and Cohorts

  • Sepsis patients
    • Patients admitted to the intensive care unit with sepsis diagnosed or suspected
  • Surgical patients
    • Previously healthy patients who are operated for colon cancer with laparoscopic technique.

Clinical Trial Outcome Measures

Primary Measures

  • Hemodynamics
    • Time Frame: Repeated measures at 10am, 12am, 2pm, 4pm,6pm, and 8pm
    • Systemic and regional hemodynamics

Secondary Measures

  • Metabolic alterations
    • Time Frame: Repeated measures at 10am, 12am, 2pm, 4pm,6pm, and 8pm
    • Renal arginine metabolism

Participating in This Clinical Trial

Inclusion Criteria sepsis group:

  • Sepsis diagnosed or suspected – Normal premorbid serum creatinine measured or anticipated (if data are not available) – Normovolemia as indicated by a pulse pressure variation less than 12% Comparator group – Previously healthy individuals scheduled for laparoscopic colon cancer resection – Normal creatinine levels within 3 months before admittance to hospital. – Patients admitted to the intensive care unit with sepsis diagnosed or suspected – Previously healthy patients listed for elective colon cancer surgery Exclusion Criteria:

-

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital of North Norway
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Lars M Ytrebo, MD PhD, +4790788058, lars.marius.ytrebo@unn.no

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.